HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 205 filers reported holding HERON THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $838,000 | -57.7% | 146,436 | -32.5% | 0.09% | -44.3% |
| Q4 2021 | $1,982,000 | -22.3% | 217,028 | -9.1% | 0.17% | -25.8% |
| Q3 2021 | $2,552,000 | -32.8% | 238,707 | -2.5% | 0.22% | -32.2% |
| Q2 2021 | $3,800,000 | -12.2% | 244,793 | -8.3% | 0.33% | -17.6% |
| Q1 2021 | $4,327,000 | -23.3% | 266,899 | +0.2% | 0.40% | -18.9% |
| Q4 2020 | $5,639,000 | +14.1% | 266,415 | -20.1% | 0.50% | +29.1% |
| Q3 2020 | $4,943,000 | -6.9% | 333,501 | -7.7% | 0.38% | -13.7% |
| Q2 2020 | $5,312,000 | +17.3% | 361,141 | -6.4% | 0.45% | -3.9% |
| Q1 2020 | $4,528,000 | -19.7% | 385,729 | +60.7% | 0.46% | +12.1% |
| Q4 2019 | $5,640,000 | +14.7% | 240,024 | -9.7% | 0.41% | +11.9% |
| Q3 2019 | $4,917,000 | +143.8% | 265,804 | +145.0% | 0.37% | +166.2% |
| Q2 2019 | $2,017,000 | -37.2% | 108,495 | -17.4% | 0.14% | -31.9% |
| Q1 2019 | $3,210,000 | – | 131,343 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |